Buy generic drugs

Each dose of 0.5ml contains: protein L1 HPV type 6; Protein L1 HPV Type 11; Protein L1 HPV Type 16; Protein L1 HPV Type 18; Protein L1 HPV for each type 31,33,45,52 and 58.

N1

30mcg; 40mcg; 60mcg; 40mcg; 20mcg; 20mcg; 20mcg; 20mcg; 20mcg/0.5ml

Intramuscularly

Injection

Syringe

30

After reconstitutioning 01 dose (0.5ml) contains: Diphore detox ≥ 30iu; Tetanintic detox ≥ 40iu; Bordetella pertussis antigens include 25mcg pertussis detoxification and 25MCG and 8MCG -shaped red blood cells; Antigen surface of hepatitis B virus 10mcg; Virus polio type 1 inactivation (Mahoney) 40du; Inactive 2-type virus (MEF-1 strain) 8DU; Viral virus is inactive 3 (afterket) 32du; Haemophilus Influenza's polysaccharide category B 10mcg plus 25mcg tetanus detoxification such as carrier protein

N1

≥ 30 IU; ≥ 40 IU; 25 mcg; 25 mcg; 8 mcg; 10mcg; 40 Du; 8 travel; 32 travel; 10mcg plus with 25mcg tetanus detoxification

Intramuscularly

Hib dried freeze powder and philanology (DTPA-HBV-IPV) to mix the injection mixture

Dose

30

Each dose (0.5ml) contains: Polysaccharide of serum types 11,2, 51,2, 6b1,2, 7f1,2, 9v1,2, 141,2, 23f1,2 and serum types 41,2, 18C1.3, 19f1,4

N1

1mcg; 3MCG

Intramuscularly

Injection

Dose

50

Type 1 polysaccharid pneumococcal polysaccharid 2.2mcg; Type 3 polysaccharide pneumococcal bacteria 2.2mcg; Type 4 polysaccharide pneumococcal pneumococcal bacteria 2.2mcg; Type 5 polysaccharide pneumococcal bacteria 2.2mcg; Type 6A polysaccharide pneumococcal bacteria 2.2mcg; Type 6b polysaccharid pneumococcal pneumococcal pneumococcal pneumococcal. Type 7f polysaccharide pneumococcal bacteria 2.2mcg; Type 9V polysaccharide pneumococcal bacteria 2.2mcg; Type 14 polysaccharide pneumococcal pneumococcal bacteria 2.2mcg; Type 18C polysaccharide pneumococcal pneumococcal bacteria 2.2mcg; Type 19A polysaccharid pneumococcal pneumococcal bacteria 2.2mcg; Type 19f polysaccharide pneumococcal bacteria 2.2mcg; Tip serum 23F polysaccharid pneumococcal bacteria 2.2mcg; Plus the protein for transporting CRM197 32MCG

N1

2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 4.4mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 32mcg/0.5ml

Inject

Injection

Syringe

20

Each dose of 0.5 ml of reverting vaccine contains: Japanese encephalitis virus SA14-14-2 recombinant, living, reducing poison

N5

4.0 - 5.8 log pfu

Inject

Dried powder

Jar

10

3% hydrogen peroxide

N4

3%/50ml

External

External solution

Jar

200

Articain hydrochloride + adrenaline (in the form of adrenaline tartrate)

N1

(68mg + 0.017mg)/1.7ml

Inject

Injection solution used in dentistry

Tube

1